After the death of children, MP AYUSH department seized Ayurvedic medicines and sent samples for testing

New Delhi:  Following the death of a five-month-old baby in Madhya Pradesh’s Chhindwara after allegedly consuming Ayurvedic medicines, the state government’s AYUSH department has seized the medicines and sent samples for testing and other necessary legal action, the AYUSH Ministry said on Friday.

The Ministry of AYUSH said that the Ministry is actively coordinating with the State authorities to ensure the highest standards of safety and quality in AYUSH medicines and to promote their safe and effective use for public welfare.

The Ministry of AYUSH is committed to ensuring the safety and quality standards of AYUSH medicines and from time to time issues necessary instructions to the State and Union Territory (UT) governments to ensure compliance with the provisions under the Drugs and Cosmetics Act, 1940 and the Drugs Rules, 1945, the ministry said in a statement.

The enforcement of legal provisions relating to quality control of Ayurveda, Siddha, Unani, Sowa-Rigpa and Homeopathy drugs/medicines and issuance of drug licences is vested with the State Drug Controllers/State Licensing Authorities appointed by the respective State and Union Territory Governments, the statement said.

It said the concerned State and Union Territory licensing authorities have the power to take action against misbranded, adulterated and spurious AYUSH medicines.

“As per the information received from the Drug Control Department, AYUSH, Government of Madhya Pradesh, immediate action has been taken in this regard, which includes seizure of the alleged drugs, sending samples for testing and other necessary legal action,” the statement said.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit